Pepstatin, an acid protease inhibitor purified from the culture medium of Actinoinycetes, had a strong diuretic effect in C3H/He mice. A single subcutaneous injection of pepstatin at 80 mg/kg body weight caused 3-to 4-fold increase in the urine volume over that of control mice during the first 24 hours after the injection and 6-to 7-fold increase during the second and third 24-hour periods. The effect was maximal after 7296 hours, and gradually disappeared within 168 hours after the injection. The serum potassium concentration increased to 7.6 mEq/liter at 24 hours after the injection but the serum sodium concentration did not change significantly.
Pepstatin is known to inhibit many acid proteases such as pepsin, cathepsin D and renin. 1, 2) These inhibitory effects of pepstatin are considered to be useful in treatment of peptic ulcers and hypertension.3)
GREENBAUM et al. reported that pepstatin effectively inhibited ascites accumulation in mice bearing L1210 and mastocytoma.4) Recently, we confirmed this inhibition of ascites accumulation in mice bearing various other types of ascites tumors (to be published). This inhibitory effect was suggested to be due to inhibition of a cathepsin D-like enzyme that increases vascular permeability through formation of leukokinin, a vasoactive peptide,5) from leukokininogen. During studies of the mechanism of inhibition of ascites accumulation we found that pepstatin has a strong diuretic effect. This paper reports studies on this diuretic effect of pepstatin and a consideration of the mechanism of this effect. Measurement of urine volume Each mouse was kept in a separate metabolic cage (Natsume Seisakusho, Tokyo, Japan) with free access to pellet diet (CLEA CE-2) and water. Urine was collected for 24-hour periods for determination of its volume.
Determination of serum sodium (Na) and potassium (K) Blood was collected by puncture of subaxillary vessels under ether anesthesia and the serum was separated by centrifugation. Serum Na and K were determined by flame photometry using a Hitachi flame photometer 205D (Hitachi Seisakusho, Co., Ltd., Tokyo, Japan) by courtesy of Dr. E. ARAKI, National Cancer Center Hospital, Tokyo, Japan.
Results
The strong diuretic effect of pepstatin is shown in Fig. 1 . In this experiment, a single subcutaneous injection of 80 mg/kg of pepstatin caused 3-to 4-fold increase in urine volume during the first 24 hours, and 6-to 7-fold increase during the second and the third 24-hour periods and then its effect gradually decreased. The maximal diuretic effect was observed during the third 24-hour period. A dose of 40 mg/kg of pepstatin was as effective during the first 24 hours, but its diuretic effect decreased during the second 24-hour period and disappeared within 72 hours. These data show that the effect of pepstatin is dose-dependent and reversible.
The diuretic effect of the very water-soluble derivative of pepstain, lactyl-pepstatin was also studied. The 1D50 of this derivative for renin (1.7 x 10-4 M) is two orders of magnitude higher than that of pepstatin. This derivative had no significant diuretic effect when injected subcutaneously at a dose of 69 mg/kg, which is equivalent to 80 mg/kg of pepstatin (data not shown).
The effect of 80 mg/kg of pepstatin on the serum Na and K levels was studied and the results are shown in Fig. 2 . The serum K level showed a reversible increase with a maximum of 7.6 mEq/liter at 24 hours after subcutaneous pepstatin injection. The serum Na level also increased slightly, but since the control group showed the same increase, this increase did not seem to be a specific effect of pepstatin. Stalin was reported to be useful for inhibiting ascites accumulation associated with cancer in mouse ascites tumor L1210 and mastocytoma P815-Y4) and we confirmed this effect in other systems (to be published).
Originally this inhibitory effect of pepstatin was supposed to be due to inhibition of a cathepsin D-like enzyme that forms leukokinin from leukokininogen. 4) However, since pepstatin has a strong diuretic effect, as shown in this paper, the reduction of ascites associated with cancer might be at least partly due to the diuretic effect.
The diuretic effect of pepstatin is probably due to an indirect antagonistic effect on aldosterone, because pepstatin increased the serum K level and this effect was reversible.
Moreover, pepstatin is known to be a strong inhibitor of renin.2) Renin is known to produce angiotensin I from angiotensinogen and a high level of angiotensin II, which is produced from angiotensin I by the converting enzyme, causes a high level of aldosterone.
This possibility is supported by the finding that at the same molar dose as pepstatin, lactyl-pepstatin had no significant diuretic effect. Lactyl-pepstatin has been found to have an ID50 for renin two orders higher than that of pepstatin (Dr. T. AOYAGI, Institute of Microbial Chemistry, Tokyo, personal communication).
The possible clinical use of pepstatin and its derivatives requires investigation.
